T1	Participants 0 66	Risperidone versus haloperidol in children and adolescents with AD
T2	Participants 151 227	to compare safety, efficacy and tolerability of risperidone with haloperidol
T3	Participants 235 271	treatment of Autistic Disorder (AD).
T4	Participants 335 356	for a 12-week period.
T5	Participants 366 470	f 30 subjects, between the ages of 8 and 18 with AD based on DSM IV criteria, were included in the study
T6	Participants 515 549	the investigators and the parents.
T7	Participants 763 793	regimen of 0.01-0.08 mg/kg/day
T8	Participants 1578 1758	Risperidone was found to be more effective than haloperidol in the treatment of behavioral symptoms, impulsivity, language skills, and impaired social relations in children with AD
T9	Participants 1218 1358	greater increase of prolactin in the risperidone group, while alanine amino transferase (ALT) had further increased in the haloperidol group
